<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">Infection</z:e> with parvovirus B19 during pregnancy is known to be associated with various <z:e sem="disease" ids="C0854268" disease_type="Disease or Syndrome" abbrv="">fetal damage</z:e>, such as <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and <z:hpo ids='HP_0001789'>hydrops fetalis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Our objective was to study the seroprevalence of parvovirus B19 in the obstetric population in Kuwait and to compare this with that in the adult population in other regions </plain></SENT>
<SENT sid="2" pm="."><plain>Blood samples from 1047 pregnant women were used in this prospective study </plain></SENT>
<SENT sid="3" pm="."><plain>Information regarding patient's age, parity, nationality and symptoms was obtained at the time of collection of the sample </plain></SENT>
<SENT sid="4" pm="."><plain>Blood was tested for IgG and IgM antibodies specific for parvovirus B19 using the ELISA technique </plain></SENT>
<SENT sid="5" pm="."><plain>The overall prevalence for IgG and IgM was 53.3 and 2.2%, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>IgG seropositivity was higher in non-Kuwaiti women, while IgM antibodies was more frequent in Kuwaiti women </plain></SENT>
<SENT sid="7" pm="."><plain>A total of 17.4% of the acutely infected patients were symptomatic </plain></SENT>
<SENT sid="8" pm="."><plain>Prevalence of <z:e sem="disease" ids="C0085273" disease_type="Disease or Syndrome" abbrv="">parvovirus B19 infection</z:e> in Kuwait is comparable with that in the other countries </plain></SENT>
</text></document>